Skip to main content

Advertisement

SpringerLink
Log in

Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

We sought to evaluate the association of adjuvant chemotherapy with the risk of subsequent mortality among patients with locally advanced urothelial carcinoma (UC) of the bladder undergoing radical cystectomy (RC).

Methods

We identified 675 patients who underwent RC for pT2–4 and/or N+ UC between 1980 and 2005. Adjuvant chemotherapy was defined as treatment within 90 days of RC. Survival was estimated using the Kaplan–Meier method and compared according to receipt of adjuvant chemotherapy with the log-rank test. Multivariate models were used to analyze the impact of adjuvant chemotherapy on disease progression and survival.

Results

A total of 80 (12 %) patients received adjuvant chemotherapy. Median age was 69 years [interquartile range (IQR) 63, 76]. Median follow-up was 11 years (IQR 8, 16). Patients receiving adjuvant chemotherapy were more likely to have pT3–4 tumors (71 vs. 61 %; p < 0.001) and pN+ (85 vs. 19 %; p < 0.001). The 5-year cancer-specific survival was 46 % in those receiving adjuvant chemotherapy and 51 % in those that did not (p = 0.63). The 5-year overall survival was 39 % in those receiving adjuvant chemotherapy and 38 % in those that did not (p = 0.24). When controlling for age, sex, stage, and performance status, adjuvant chemotherapy was associated with a 29 % decrease in the risk of bladder cancer death (HR 0.71, p = 0.06) and a 39 % decrease in the risk of all-cause mortality (HR 0.61, p = 0.002).

Conclusions

After controlling patient and tumor features, adjuvant chemotherapy was associated with a trend toward reduction in cancer-specific mortality and a statistically significant reduction in all-cause mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

RC:

Radical cystectomy

UC:

Urothelial carcinoma

CI:

Confidence interval

CSS:

Cancer-specific survival

OS:

Overall survival

IQR:

Interquartile range

ECOG:

Eastern Cooperative Oncology Group

HR:

Hazard ratio

RR:

Relative risk

References

  1. Dalbagni G, Genega E, Hashibe M, Zhang ZF, Russo P, Herr H, Reuter V (2001) Cystectomy for bladder cancer: a contemporary series. J Urol 165(4):1111–1116

    Article  CAS  PubMed  Google Scholar 

  2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675

    CAS  PubMed  Google Scholar 

  3. Ghoneim MA, El-Mekresh MM, El-Baz MA, El-Attar IA, Ashamallah A (1997) Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 158(2):393–399

    Article  CAS  PubMed  Google Scholar 

  4. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176(6 Pt 1):2414–2422. doi:10.1016/j.juro.2006.08.004; discussion 2422

    Article  PubMed  Google Scholar 

  5. Hautmann RE, de Petriconi RC, Pfeiffer C, Volkmer BG (2012) Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1,100 patients. Eur Urol 61(5):1039–1047. doi:10.1016/j.eururo.2012.02.028

    Article  PubMed  Google Scholar 

  6. Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 29(16):2171–2177. doi:10.1200/JCO.2010.32.3139

    Article  CAS  PubMed  Google Scholar 

  7. Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP Jr, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866. doi:10.1056/NEJMoa022148

    Article  CAS  PubMed  Google Scholar 

  8. Advanced Bladder Cancer Meta-analysis Collaboration (2003) Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361(9373):1927–1934

    Google Scholar 

  9. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48(2):202–205; discussion 205–206. doi:10.1016/j.eururo.2005.04.006

    Google Scholar 

  10. International Collaboration of Trialists (1999) Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354(9178):533–540

    Google Scholar 

  11. Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696

    Article  CAS  PubMed  Google Scholar 

  12. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48(2):189–199; discussion 199–201. doi:10.1016/j.eururo.2005.04.005

    Google Scholar 

  13. Ruggeri EM, Giannarelli D, Bria E, Carlini P, Felici A, Nelli F, Gallucci M, Cognetti F, Pollera CF (2006) Adjuvant chemotherapy in muscle-invasive bladder carcinoma: a pooled analysis from phase III studies. Cancer 106(4):783–788. doi:10.1002/cncr.21676

    Article  CAS  PubMed  Google Scholar 

  14. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Nichols P, Kern W, Sakamoto J, Krailo M, Groshen S (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145(3):459–464; discussion 464–457

    CAS  PubMed  Google Scholar 

  15. Stockle M, Meyenburg W, Wellek S, Voges G, Gertenbach U, Thuroff JW, Huber C, Hohenfellner R (1992) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 148(2 Pt 1):302–306; discussion 306–307

    CAS  PubMed  Google Scholar 

  16. Studer UE, Bacchi M, Biedermann C, Jaeger P, Kraft R, Mazzucchelli L, Markwalder R, Senn E, Sonntag RW (1994) Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152(1):81–84

    CAS  PubMed  Google Scholar 

  17. Freiha F, Reese J, Torti FM (1996) A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155(2):495–499; discussion 499–500

    Article  CAS  PubMed  Google Scholar 

  18. Bono AV, Benvenuti C, Reali L, Pozzi E, Gibba A, Cosciani-Cunico S, Comuzzi U, Anselmo G (1989) Adjuvant chemotherapy in advanced bladder cancer. Italian Uro-Oncologic Cooperative Group. Prog Clin Biol Res 303:533–540

    CAS  PubMed  Google Scholar 

  19. Otto T, Borgermann C, Krege S (2001) Adjuvant chemotherapy in locally advanced bladder cancer (pT3/pN1–2, M0): a phase III study. Eur Urol 39:147

    Google Scholar 

  20. Paz-Ares L, Solsona E, Esteban E (2010) Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 study [abstract LBA4518]. J Clin Oncol 28:7s

    Article  Google Scholar 

  21. Cognetti F, Ruggeri EM, Felici A, Gallucci M, Muto G, Pollera CF, Massidda B, Rubagotti A, Giannarelli D, Boccardo F (2012) Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial. Ann Oncol 23(3):695–700. doi:10.1093/annonc/mdr354

    Article  CAS  PubMed  Google Scholar 

  22. Power NE, Kassouf W, Bell D, Aprikian AG, Fradet Y, Lacombe L, Chin J, Izawa J, Estey E, Fairey A, Cagiannos I, Lattouf JB, Drachenberg D, Rendon RA (2012) Natural history of pT3–4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort. Can Urol Assoc J 6(6):E217–E223. doi:10.5489/cuaj.11012

    PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, Mayo Medical School and Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA

    Daniel A. Yelfimov, Igor Frank, Stephen A. Boorjian & Matthew K. Tollefson

  2. Department of Health Sciences Research, Mayo Medical School and Mayo Clinic, Rochester, MN, 55905, USA

    Prabin Thapa

  3. Department of Pathology, Mayo Medical School and Mayo Clinic, Rochester, MN, 55905, USA

    John C. Cheville

Authors
  1. Daniel A. Yelfimov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Igor Frank
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen A. Boorjian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prabin Thapa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John C. Cheville
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Matthew K. Tollefson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel A. Yelfimov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yelfimov, D.A., Frank, I., Boorjian, S.A. et al. Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer. World J Urol 32, 1463–1468 (2014). https://doi.org/10.1007/s00345-014-1236-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-014-1236-2

Keywords

Search

Navigation